1. Catalogs
  2. HAEMONETICS
  3. TEG and PlateletMapping give you a clearer picture of coagulation

TEG and PlateletMapping give you a clearer picture of coagulation

TEG and PlateletMapping give you a clearer picture of coagulation

Product catalog summary

Overview: The document discusses the TEG® 5000 System, a medical device designed to provide comprehensive information on the coagulation process, including platelet function, to aid in targeted treatment for surgical patients.

Key Features:

  • The TEG® 5000 System offers insights into each key part of the coagulation process, which is crucial for assessing bleeding or thrombosis risks in surgical patients.
  • It includes PlateletMapping assays that evaluate platelet participation in clot formation, both with and without anti-platelet drugs, relative to overall clot strength.

Clinical Questions Addressed:

  • How is the patient's platelet function responding to anti-platelet therapy, and what is the impact on coagulation?
  • What is the patient's risk of bleeding during surgery?
  • Is the patient protected from deep vein thrombosis (DVT), pulmonary embolism (PE), or other thrombotic risks post-surgery and before discharge?

Benefits: The TEG System consolidates key coagulation components into a single test, aiding in the identification of coagulopathy nature and guiding hemostasis treatment with appropriate blood products.

Contact Information: For further details, contact a local Haemonetics Hemostasis Consultant or visit the provided websites.

Additional Information: The document includes a visual representation comparing platelet function across different patient profiles (hypercoagulable, hypocoagulable, and normal).

See more

Catalog excerpts

TEG and PlateletMapping give you a clearer picture of coagulation-1

How complete is your information to know your surgical patients’ chances of bleeding or thrombosis? Patient A Total platelet function (baseline) The TEG® 5000 System provides valuable information on each key part of the coagulation process, including platelet function, to help guide a more targeted treatment. TEG and PlateletMapping give you a clearer picture of coagulation ® Coagulation is a complex process and routine tests provide only pieces of the process. The PlateletMapping assays measure the ability of platelets to participate in clot formation, with and without the effect of anti-platelet drugs relative to the overall clot strength. The TEG System provides information to help you answer these questions: n How is the patient’s platelet function responding to their anti-platelet therapy and what is the effect on their coagulation? What is their risk of bleeding during surgery? Is the patient protected from DVT/PE or other thrombotic risks after surgery and prior to discharge? The power of the TEG System is that it provides the key components of coagulation in ONE test to help you identify the nature of the coagulopathy and guide the hemostasis treatment with the right blood product. For more information, please contact your local Haemonetics Hemostasis Consultant or visit www.Haemoscope.com. www.haemonetics.com Rx Only © Copyright 2011 Haemonetics Corporation. Haemonetics, Haemonetics The Blood Management Company and TEG are trademarks or registered trademarks of Haemonetics Corporation in the USA, other countries, or both. PlateletMapping is a trademark of Cora Healthcare Inc. 06.2015 USA. COL-COPY-000449(AB) Haemonetics Corporation

 Open the catalog to page 1

All HAEMONETICS catalogs and technical brochures

  1. NexSys PCS

    6  Pages

  2. PCS 2

    4  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.